Search This Blog

Saturday, January 29, 2022

Biden pressured to cover COVID-19 tests through Medicare

 The Biden administration is exploring ways for Medicare beneficiaries to get over-the-counter, at-home COVID-19 tests for free.

The White House is requiring private insurance companies to cover the cost of eight at-home COVID-19 tests per person each month, if the customer files for reimbursement. The requirement was put in place as a result of the massive surge in infections due to the omicron variant.

But the policy doesn't apply to Medicare beneficiaries, and the exclusion of 64 million older and disabled Americans has triggered a backlash.

Dozens of Democratic lawmakers and advocates have pressed the administration in recent days to change the rules, but the options to do so are limited, as Medicare typically doesn't cover home-use diagnostic tests. 

“I am disappointed that the reimbursement option for eight additional at-home tests per month per person only applies to those with private or group health insurance,” Rep. Anna Eshoo (D-Calif.) wrote to Health and Human Services (HHS) Secretary Xavier Becerra

“Without comparable benefits available through Medicare, more than 18 percent of our nation’s population will be made to pay out-of-pocket for additional at-home COVID-19 tests. Americans enrolled in Medicare are among the most susceptible and vulnerable to infection, so it’s paramount that this population is given priority access to critical testing measures,” Eshoo wrote.

Currently, traditional Medicare only pays for COVID-19 diagnostic tests performed by a laboratory, such as PCR and antigen tests. If the test is ordered by a physician, pharmacist or “authorized health care professional,” there's no cost to the beneficiary. 

Biden health officials said they are "working nonstop" to find a way to solve the issue.

“Over-the-counter tests have not been paid for as a Medicare benefit, but we’re going through the process now to explore options and work through statutory and regulatory issues as we drive toward solutions,” Meena Seshamani, director of the Center for Medicare and deputy administrator of the Centers for Medicare and Medicaid Services said in a statement to The Hill. 

“We recognize testing remains a critical tool to help mitigate the spread of COVID-19, and we are committed to providing resources to keep Medicare beneficiaries safe and healthy,” Seshamani added. 

During a recent briefing, White House coronavirus task force coordinator Jeff Zients noted that Medicare beneficiaries already have access to free testing at tens of thousands of free-standing sites nationwide. 

The administration is also providing 50 million testing kits to thousands of community health centers and Medicare-certified rural health clinics for distribution to patients and community members. 

Beneficiaries can also order four tests per household from the federal website CovidTests.gov and have them shipped by the U.S. Postal Service. 

Medicare Advantage, where beneficiaries join private managed care plans, is also a possibility, though each company sets its own rules and coverage varies. 

Older adults are most at-risk of severe complications from COVID-19, and expanding their access to tests could slow transmission. And as new treatments are developed that require early intervention, at-home tests are becoming even more important. 

Advocates and lawmakers said HHS has issued waivers and emergency rules for other Medicare policies during the pandemic, and should be flexible with coverage of at-home tests as well.

“Seniors and people with disabilities enrolled in Medicare are at the highest risk of severe illness from COVID-19, and people over 65 account for nearly three-quarters of all deaths from the virus. The current policy leaves them on the hook for potentially significant out-of-pocket costs,” a group of 19 Senate Democrats, led by Rep. Debbie Stabenow (D-Mich.), wrote in a letter to HHS. 

Casey Schwarz, senior counsel at the Medicare Rights Center, said the available options for seniors can be burdensome.

“Lab testing for COVID is covered as many times as your provider orders it, which means that you need to contact your primary care provider, and then explain why you need a test ... and then they need to order it, and then you need to go to the testing site they ordered it at. All of these steps can increase the barriers,” Schwarz said.

Schwarz said Medicare coverage is determined by statute, and changing it is not easy. The absolute simplest way is congressional action, but she said the administration shouldn't wait for lawmakers, because it may not happen quickly, or at all.  

The administration has some authority to waive certain Medicare requirements under the current public health emergency, but she said “the exact parameters of that authority are subject to some interpretation.”

“There's no real sound policy reason that this population should be without insurance coverage for tests. It's a product of how Medicare is designed,” Schwarz said.

The other problem is that Medicare isn’t set up to simply reimburse beneficiaries who purchase tests like private insurance does. Medicare pays providers, not individuals.

“So there's some logistical matters that are somewhat unique to Medicare. For the immediate term, that's the hard part— figuring out, is there a way to do it under existing law?” said Jack Hoadley, a research professor emeritus at Georgetown University. 

While the administration assesses its options, Schwarz said Medicare in the interim should expand coverage for lab tests so they can be more accessible.

“There are some things that might be easier and some things that might be harder,” Schwarz said. “Getting to the point where everyone with Medicare can go can order a test online and submit a receipt for reimbursement? I think that's pretty hard. Expanding coverage in some way? That seems more doable.”

https://thehill.com/policy/healthcare/591882-biden-pressured-to-cover-covid-19-tests-through-medicare

AstraZeneca China summoned over suspected fraud

 Chinese authorities summoned officials of AstraZeneca China regarding an investigation of suspected medical insurance fraud by the company's employees, the National Healthcare Security Administration (NHSA) said on Saturday.

The regulator of the state medical insurance fund said authorities ordered the arrest of all suspects, but did not give details of the suspected violations or the size of funds involved.

It demanded that AstraZeneca China close loopholes in supervision of marketing activities, the NHSA added.

In a statement on Friday, the company said some employees in the southern city of Shenzhen had altered or participated in altering patients' testing reports, and were suspected of medical insurance fraud.

The NHSA and public security ministry held a meeting with company officials in December to brief them on the investigation, it added.

"AstraZeneca China takes such employee misconduct seriously and welcomes the recommendations by the NHSA and MOPS," it said.

An AstraZeneca spokesperson said all employees involved in the Shenzhen case were Chinese nationals.

The company has taken disciplinary action against those employees and has reported their violations to the authorities, the statement said.

Authorities will launch nationwide campaigns to stamp out fraud that involves altering genetic test results, the NHSA added, urging those responsible for such violations to turn themselves in.

https://www.marketscreener.com/quote/stock/ASTRAZENECA-PLC-4000930/news/AstraZeneca-China-summoned-over-suspected-fraud-37678295/

Trucks roll into Ottawa for protest against Canada's vaccine mandates

 Trucks rolled into Canada's capital Ottawa on Saturday to stage what police say will be a massive protest against Prime Minister Justin Trudeau's COVID-19 vaccine mandates in front of parliament on a frigid winter day.

The so-called "Freedom Convoy" - coming from east and west - started out as a rally against a vaccine requirement for cross-border truckers https://www.reuters.com/markets/commodities/canada-resists-pressure-drop-vaccine-mandate-cross-border-truckers-2022-01-09, but has turned into a demonstration against government overreach during the pandemic with a strong anti-vaccination streak.

Public Safety Minister Marco Mendicino told the Canadian Broadcasting Corp. (CBC) on Friday that some of the protesters have expressed "flagrant extremism," including calling for the violent overthrow of the government.

Trudeau told the Canadian Press on Friday he was worried about the protest turning violent. Earlier this week he said the convoy represented a "small fringe minority" who do not represent the views of Canadians.

On Saturday the CBC said Trudeau and his family have left the home where they live in downtown Ottawa due to security concerns and he is working from another location. His office would not confirm the report.

About 90% of Canada's cross-border truckers and 77% of the population have had two COVID vaccination shots.

The main convoys are scheduled arrive around noon, but already on Friday vehicles blocked the roads in front of parliament and on Saturday morning there were dozens of trucks gathered. A total of some 2,700 trucks are expected, a federal government source said.

The demonstration will be "massive in scale," Ottawa police chief Peter Sloly said on Friday. Protest organizers have said the rally will be peaceful, and they have vowed to remain in Ottawa until they succeed in overturning the mandates.

Canada's Meteorological Service has issued an extreme cold warning for Saturday morning, saying the wind chill could be near minus 35 Celsius (minus 31 Fahrenheit).

Trudeau announced a vaccine mandate for federal workers in October on the eve of the election, and then last month both Canada and the United States imposed one for cross-border truckers.

Conservative leader Erin O'Toole opposes vaccine mandates and expressed support for the protest https://www.reuters.com/article/health-coronavirus-canada-trucking/beleaguered-trudeau-rival-embraces-trucker-protest-despite-concerns-of-violence-idINL8N2U76M7?edition-redirect=in after holding talks with some of the truckers on Friday.

"I support their right to be heard, and I call on Justin Trudeau to meet with these hard-working Canadians to hear their concerns," O'Toole said after the meeting. "Please protest safely this weekend."

The Canadian Trucking Alliance, which represents some 4,500 carriers, owner-operators and industry suppliers, opposes the demonstration and has said this is "not how disagreement with government policies should be expressed."

https://www.marketscreener.com/quote/stock/EDITION-LTD-6811780/news/Trucks-roll-into-Ottawa-for-protest-against-Canada-s-vaccine-mandates-37678501/

Bargain hunters study stock valuations after big declines

 

A steep slide in U.S. stocks has investors gauging equity valuations to determine whether now is the time to scoop up shares at a bargain.

The S&P 500 has dropped over 9% so far in 2022, while the tech-heavy Nasdaq stands in correction territory after a nearly 15% fall. The market sank again this week after the Federal Reserve signaled it is likely to raise U.S. interest rates in March before shrinking its balance sheet later in the year.

Buying after pullbacks paid off for many investors over the last two years, when the Fed's ultra-easy monetary policies during the pandemic buoyed stocks from one record high to the next.

With the market now pricing in almost five rate hikes by the end of 2022, that calculus has changed dramatically.

"The convergence of monetary and fiscal policy, which was historically dovish and ample, now is changing course and the equity markets as well as other risk markets are slowly coming to terms with that sobering reality," said Chad Morganlander, portfolio manager at Washington Crossing Advisors.

The slide in stocks has brought down the valuation of the overall S&P 500, which at the end of 2021 stood not far from its highest level in two decades. The index now trades at 19.5 forward 12 months earnings, compared to 22 times earnings in late December and its five-year average of 18.5, according to Refinitiv IBES.

The market's fall hadn't been precipitous enough for Barclays strategists, who early this week declared in a note it was still "too early to buy the dip." An analysis of pre-pandemic equity valuations showed the index could decline another roughly 8% from the 4,410.13 level where it closed on Monday, Barclays strategists said in a report. The S&P 500 was recently at 4,330, about 2% below Monday's level.

Other valuation metrics are more favorable to stocks. A look at the equity risk premium - or the extra return investors receive for holding stocks over risk-free government bonds - favors equities over the next year, according to Keith Lerner, co-chief investment officer at Truist Advisory Services.

When that premium historically has been at the level it reached on Wednesday, the S&P 500 has beaten the one-year return for the 10-year Treasury note by an average of 11.8%, Lerner said. The yield on the benchmark 10-year Treasury has climbed about 30 basis points this year to 1.81% but remains low by historical standards.

"At least right now, even though there could be more volatility, until and unless the Fed actually makes a mistake or there is actually a recession, you still want to stick with stocks over bonds," said Sameer Samana, senior global market strategist at the Wells Fargo Investment Institute.

The strength of fourth-quarter corporate results, which continue to roll in with S&P 500 earnings season not yet at the halfway point, could bolster the case for investors looking to buy at a discount.

With S&P 500 earnings expected to grow 8.4% in 2022, the backdrop for stocks appears to be a solid one. However, skittish investors have punished companies such as Netflix, JPMorgan and Tesla delivering less than stellar news in recent weeks, adding to the uneasy mood. Another large batch of reports is due next week, including from heavyweights Alphabet and Amazon.

"Heading into 2022, our view was that equities could earn their way out of rising yields and lower P/E multiples. Our new base case for six hikes this year poses challenges to that bullish outlook," analysts at BNP Paribas wrote.

Nevertheless, the bank said investors should "stay the course" in equities, as the "outlook for above-trend growth and inflation still translates to above consensus double-digit earnings growth for 2022."

https://www.marketscreener.com/quote/stock/ALPHABET-INC-24203373/news/Bargain-hunters-study-stock-valuations-after-big-declines-37675546/

Russia moves blood supplies near Ukraine, adding to U.S. concern, officials say

 

Russia's military buildup near Ukraine has expanded to include supplies of blood along with other medical materials that would allow it to treat casualties, in yet another key indicator of Moscow's military readiness, three U.S. officials tell Reuters.

Current and former U.S. officials say concrete indicators -- like blood supplies -- are critical in determining whether Moscow would be prepared to carry out an invasion, if Russian President Vladimir Putin decided to do so.

The disclosure of the blood supplies by U.S. officials, speaking on condition of anonymity, adds another piece of context to growing U.S. warnings that Russia could be preparing for a new invasion of Ukraine as it masses more than 100,000 troops near its borders.

These warnings have included President Joe Biden's prediction that a Russian assault was likely and U.S. Secretary of State Antony Blinken's remarks that Russia could launch a new attack on Ukraine at "very short notice."

The Pentagon has previously acknowledged the deployment of "medical support" as part of Russia's buildup. But the disclosure of blood supplies adds a level of detail that experts say is critical to determining Russian military readiness.

"It doesn't guarantee that there's going to be another attack, but you would not execute another attack unless you have that in hand," said Ben Hodges, a retired U.S. lieutenant general now with the Center for European Policy Analysis research institute.

The Russian Defence Ministry did not immediately respond to a written request for comment

Ukraine's deputy defence minister Hanna Malyar denied the information.

"This information is not true. Such 'news' is an element of information and psychological war. The purpose of such information is to spread panic and fear in our society," she said on Facebook.

On Friday, Ukraine's President Volodymyr Zelenskiy criticised a "feeling abroad" that a war had already started. "We don't need this panic," he told reporters in Kyiv.

A White House spokesperson did not immediately comment on any Russian movement of blood supplies but noted repeated public U.S. warnings about Russian military readiness.

The Pentagon declined to discuss intelligence assessments.

SECURITY DEMANDS

The three U.S. officials who spoke about the blood supplies declined to say specifically when the United States detected their movement to formations near Ukraine. However, two of them said it was within recent weeks.

Russian officials have repeatedly denied planning to invade. But Moscow says it feels menaced by Kyiv's growing ties with the West.

Eight years ago it seized Crimea and backed separatist forces who took control of large parts of eastern Ukraine.

Russia's security demands, presented in December, include an end to further NATO enlargement, barring Ukraine from ever joining and pulling back the alliance's forces and weaponry from eastern European countries that joined after the Cold War.

Putin said on Friday the United States and NATO had not addressed Russia's main security demands in their standoff over Ukraine but that Moscow was ready to keep talking.

Biden has said he will not send U.S. or allied troops to fight Russia in Ukraine but told Ukraine's Zelenskiy in a phone call on Thursday that Washington and its allies stand ready to respond decisively if Russia invades the former Soviet state, the White House said.

The United States and its allies have said Russia will face tough economic sanctions https://www.reuters.com/markets/europe/how-financial-western-sanctions-might-target-russia-2022-01-19 if it attacks Ukraine.

Western countries have already imposed repeated rounds of economic sanctions since Russian troops seized and annexed Ukraine's Crimea peninsula in 2014.

But such moves have had scant impact on Russian policy, with Moscow, Europe's main energy supplier, calculating that the West would stop short of steps serious enough to interfere with gas exports.

https://www.marketscreener.com/news/latest/Exclusive-Russia-moves-blood-supplies-near-Ukraine-adding-to-U-S-concern-officials-say--37675959/

Vitamin D supplements reduce risk of autoimmune disease

 Vitamin D supplements prevent people developing an autoimmune disease, at least for those over 50, in a study providing the first evidence of a causal link between the two.

Previous studies on the effect of vitamin D on autoimmune conditions have looked at vitamin D levels in those with an autoimmune disease or in those who go on to develop one. Other studies have hinted at the supplement’s beneficial effects on the immune system.

“We know vitamin D does all kinds of wonderful things for the immune system in animal studies,” says Karen Costenbader at the Brigham and Women’s Hospital in Boston. “But we have never proven before that giving vitamin D can prevent autoimmune disease.”

Costenbader and her colleagues randomly split nearly 26,000 people in the US who were 50 or over into two groups, giving them either vitamin D supplements or a placebo.

“The great thing about randomised trials is they really answer the question of causation,” says Costenbader.

The team tracked the participants for around five years to measure the development of autoimmune conditions, including rheumatoid arthritis, autoimmune thyroid disease and psoriasis.

This revealed that a dose of 2000 international units (IU) of vitamin D per day reduced the development of autoimmune disease by 22 per cent, compared with the placebo. This is a larger dose than the standard 400 IU recommended by health organisations such as the UK’s Department of Health and Social Care.

It is unclear how vitamin D prevents autoimmune disease, but we know it is processed in the body to produce an active form that can alter the behaviour of immune cells.

“There are tonnes of potential mechanisms,” says Costenbader. “It could be that vitamin D helps the immune system to distinguish between self [normal body tissue] and non-self [such as disease-causing microbes], or that it helps to decrease inflammatory responses to self.”

Costenbader now advises her patients to take 2000 IU of vitamin D a day, if they are the right age and it is safe for them to do so. However, she doesn’t recommend this for everyone. “You should tell your doctor if you start a supplement,” she says. “There could be reasons you shouldn’t take them.”

The researchers are now extending the trial to see how long the benefits last and hope to start a new trial in younger people. “I’m very excited and really quite bowled over by these results,” says Costenbader.

Journal reference: British Medical JournalDOI: 10.1136/bmj-2021-066452

https://www.newscientist.com/article/2306132-vitamin-d-supplements-really-do-reduce-risk-of-autoimmune-disease/

Friday, January 28, 2022

Medicaid stakeholders warn of hurdles for redeterminations process

 

  • A group of stakeholders aired their concerns over Medicaid redeterminations, which will begin once the COVID-19 public health emergency is over, before the influential advisory panel that guides Congress on issues facing the Medicaid program.
  • Last week, stakeholders told the Medicaid and Children's Health Insurance Program Payment and Access Commission that a chief concern is unnecessarily interrupting coverage for the vulnerable population.
  • They're also worried about having enough advance notice and time to process through the applications after Medicaid rolls have swelled considerably during the public health emergency.
The fallout from the pandemic caused record unemployment, which stoked fears of insurance coverage losses at a time when people needed it most: during a deadly pandemic. To ease these concerns, lawmakers paused eligibility determinations in the Medicaid program to ensure continuous coverage. Knowing it would place an additional financial burden on states, lawmakers allotted a more favorable match rate to help states insure these members. 

However, once the COVID-19 public health emergency ends, which the industry expects to happen this year, states can restart checking whether members are still eligible for coverage. While that sounds easy, stakeholders caution it's much more nuanced and not as simple as flipping a switch. 

"The stakes for getting this right are high," Melissa McChesney, health policy adviser at UnidosUS, a Latino civil rights and advocacy organization, said. McChesney warned that poor planning could trigger massive enrollment losses for eligible people. McChesney said a bungled process could deepen existing racial and ethnic disparities. 

One of the main concerns is ample time to restart this process as state agencies will likely need to make contact with members again. Panelists noted many addresses are outdated, posing a risk to continuous enrollment. 

"My first concern is: Will we really get the 12 months?" Jeff Nelson, bureau director of eligibility policy for Utah Department of Health, asked the commission. He's worried that still may not be enough time to complete the process. Previous guidance CMS has indicated states may take up to 12 months to complete the process. 

For starters, his staff needs more training. Newer staffers have never processed a Medicaid or CHIP renewal. "They don't know what this even means as we go to unwind. We've got a fifth of the workforce that potentially doesn't know what they're doing. That's going to be a problem for us," Nelson said.

Nelson is also concerned about getting enough advance warning about when the public health emergency will end, which will trigger the process of redeterminations. Given a greater lead time, there are tasks he can begin to prioritize and plan for. 

MACPAC commissioners were impressed with the panelists and seemed sympathetic to their concerns, but acknowledged in discussions following the presentation that there was likely no action yet to take. They want, however to keep a pulse on the developments. 

The redeterminations could result in a fluctuation in the nation's payer mix, which saw Medicaid rolls balloon over the course of the pandemic.

Enrollment in Medicaid and CHIP hit 83.2 million members in June 2021, a 18% increase from February 2020, according to enrollment data from CMS

Managed care firms are also bracing for Medicaid rolls to decline as members roll off due to redeterminations. Companies like Molina and Centene that have a heavy focus on government-sponsored programs reported increases in membership thanks to the redetermination pause. A broad swath of Medicaid enrollees are covered by private plans that contract with states to provide benefits to their eligible residents.

https://www.healthcaredive.com/news/macpac-hears-concerns-over-medicaid-redeterminations/617545/